Back
Vanguard Total Stock Market Index Fund ETF Vs. Nektar Therapeutics Industry Stock Comparison
Buy
70
VTI
Vanguard Total Stock Market Index Fund ETF
Last Price:
$306.09
Seasonality Move:
-0.35%
Buy
54
NKTR
Nektar Therapeutics
Last Price:
$23.83
Seasonality Move:
3.38%
Buy
70
Vanguard Total Stock Market Index Fund ETF (VTI)
is a Buy
Is Vanguard Total Stock Market Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard Total Stock Market Index Fund ETF [VTI] share price is $307.72. The Score for VTI is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
VTI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $24.41. The Score for NKTR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VTI Stock Price Chart
What is Vanguard Total Stock Market Index Fund ETF's stock price today?
-
The Vanguard Total Stock Market Index Fund ETF share price today is $307.72Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTI is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $24.41Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.
VTI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 75.88 | Buy |
Relative Strength Index (14 RSI): | 68.39 | Buy |
Chaikin Money Flow: | 1728440 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (295.4 - 305.88) | Buy |
Bollinger Bands (100): | (269.63 - 299.43) | Buy |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.02 | Buy |
Relative Strength Index (14 RSI): | 63.8 | Buy |
Chaikin Money Flow: | 4197 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.12 - 26.32) | Buy |
Bollinger Bands (100): | (7.51 - 18.15) | Buy |
VTI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 306.91 | Buy |
20-day SMA: | 301.76 | Buy |
50-day SMA: | 293.52 | Buy |
200-day SMA: | 288.55 | Buy |
8-day EMA: | 219.9 | Buy |
20-day EMA: | 120.99 | Buy |
50-day EMA: | 55.7 | Buy |
200-day EMA: | 14.98 | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.3 | Buy |
20-day SMA: | 20.35 | Buy |
50-day SMA: | 14.3 | Buy |
200-day SMA: | 14.58 | Buy |
8-day EMA: | 17.41 | Buy |
20-day EMA: | 9.54 | Buy |
50-day EMA: | 4.38 | Buy |
200-day EMA: | 1.18 | Buy |
Vanguard Total Stock Market Index Fund ETF Earnings Growth & VTI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.86 per share, and an increase next year of $0.01 per share.
Vanguard Total Stock Market Index Fund ETF Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |